MedTrace Logo

Applied Cognition Benchmarking Study

NCT06222385 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-01-24

No results posted yet for this study

Summary

This is a cross-over randomized study to validate the Sponsor investigational medical device against measurements of glymphatic function from MRI-based neuroimaging, EEG, blood biomarkers and cognitive tests in healthy older volunteers.

Conditions

  • Healthy

Interventions

DIAGNOSTIC_TEST

Device measurements during overnight sleep and morning wake

Overnight period and morning period device measurements

DIAGNOSTIC_TEST

Device measurements during overnight wake and morning sleep

Overnight period and morning period device measurements

Sponsors & Collaborators

  • University of Florida Health

    collaborator OTHER

  • Applied Cognition

    lead INDUSTRY

Principal Investigators

  • Carla Vandeweerd, PhD · UF Health

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
55 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-07
Primary Completion
2023-06-08
Completion
2023-06-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06222385 on ClinicalTrials.gov